Design Therapeutics (DSGN) Margins & Profitability 2021-2026
Gross, EBITDA, operating, and net margin trends
Margins
Profit margins across the income statement
- EBITDA Margin
- N/A
- Op. Margin
- -2217700000.0% 2.8%
- Net Margin
- -2016500000.0% 5.7%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit